在癌症幸存者的慢性疼痛
Jillian Maloney1, M Kraus2, N Strand3
1Division of Pain Medicine, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA. Maloney.jillian@mayo.edu.
Current pain and headache reports
|November 27, 2025
概括
在癌症幸存者中,慢性疼痛的管理至关重要. 杜洛西丁对化疗诱导的外围神经病变有希望,而其他类型的疼痛受益于多式疗法,包括物理治疗和注射.
科学领域:
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
- 幸存者护理 幸存者护理
背景情况:
- 癌症存活率正在增加,突出需要解决长期治疗副作用.
- 慢性疼痛综合征是癌症治疗的常见后果,如化疗,放射和手术,影响生活质量.
研究的目的:
- 审查目前的证据和治疗策略,以治疗癌症幸存者的普遍疼痛状况.
- 专注于化疗诱导的周围神经病变,辐射后疼痛和手术后疼痛综合征.
- 通过了解病理生理学,诊断和管理,指导临床医生优化幸存者护理.
主要方法:
- 对有关癌症相关疼痛综合征的现有证据进行系统审查.
- 综合有关病理生理学,诊断考虑和新兴管理策略的数据.
- 对化疗诱导的周围神经病变,辐射后疼痛和手术后疼痛的治疗方法的评估.
主要成果:
- 杜洛西丁得到了化学疗法诱导的周围神经病变的证据支持.
- 对于化学疗法诱导的外围神经病变, gabapentinoids 和三环抗抑郁药的有效性数据有限.
- 放射后和手术后疼痛综合征受益于多模式的方法,包括物理治疗,注射和药物药物.
结论:
- 建议在癌症幸存者中使用个性化和多模式的方法来管理慢性疼痛.
- 进一步的研究对于改善癌症幸存者的长期结果和生活质量至关重要.
- 优化幸存者护理需要有效管理与治疗相关的慢性疼痛.
相关概念视频
Chronic Pancreatitis I: Introduction
648
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
648
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Chronic Pancreatitis II: Collaborative Care
291
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
291
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
653
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
653
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


